Bio-Techne Corp (TECH)

200.72 +3.08  +1.56% NASDAQ Feb 26, 09:50 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
04/30/2020 08:00 CDT Misc Bio-Techne Corp Third Quarter Earnings Conference Call in 2020
04/30/2020 Earnings Bio-Techne Corp Third Quarter Earnings in 2020 Release
02/13/2020 Dividends Amount: 0.32, Declared Date: Feb 04 2020, Pay Date: Feb 28 2020
02/04/2020 08:00 CST Misc Bio-Techne Corp Second Quarter Earnings Conference Call for 2020
02/04/2020 Earnings Bio-Techne Corp Second Quarter Earnings in 2020 Release
11/07/2019 Dividends Amount: 0.32, Declared Date: Oct 29 2019, Pay Date: Nov 22 2019
10/29/2019 08:00 CDT Misc Bio-Techne Corp First Quarter Earnings Conference Call in 2020
10/29/2019 Earnings Bio-Techne Corp First Quarter Earnings in 2020 Release
10/24/2019 08:00 CDT Misc Bio-Techne Corp Annual General Meeting for 2019
08/15/2019 Dividends Amount: 0.32, Declared Date: Aug 06 2019, Pay Date: Aug 30 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.bio-techne.com
  • Investor Relations URL: https://www.bio-techne.com/investor-relations
  • HQ State/Province: Minnesota
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Apr. 30, 2020
  • Last Earnings Release: Feb. 04, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Feb. 13, 2020
  • Description: Bio-Techne Corp is a life science manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The protein sciences division's key products (78% of sales) include proteins, antibodies, and assays as well as equipment and associated consumables for protein characterization and analysis. The remaining revenue in the diagnostics and genomics segment is roughly split between manufacturing creates controls, calibrators, and reagents for diagnostic manufacturers combined with proprietary molecular and genetic testing kits. The company is split into two reporting segments namely, Protein Sciences segment and Diagnostics and Genomics segment. The Protein Sciences segment generates maximum revenue for the company.

Top Fund Holders

Symbol Name Weighting
BCSIX Brown Capital Mgmt Small Co Inv 3.39%
FBT First Trust NYSE Arca Biotech ETF 3.06%
BGRUX Baron Growth R6 2.57%
NBGAX Neuberger Berman Genesis Adv 1.99%
ECASX Eaton Vance Atlanta Capital SMID-Cap C 1.86%
XMMO Invesco S&P MidCap Momentum ETF 1.56%
HFMRX Hartford MidCap R3 1.26%
RNMC First Trust Mid Cap US Equity Select ETF 1.21%
JGMCX Janus Henderson Triton C 1.12%
IBB iShares Nasdaq Biotechnology ETF 0.94%
UBIO ProShares UltraPro Nasdaq Biotechnology 0.90%
IVOG Vanguard S&P Mid-Cap 400 Growth ETF 0.85%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.